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Abstract: Toxins of the δ/PezT family, found in the genome of major human pathogens, 
phosphorylate the peptidoglycan precursor uridine diphosphate-N-acetylglucosamine 
(UNAG) leading to unreactive UNAG-3P. Transient over-expression of a PezT variant 
impairs cell wall biosynthesis and triggers autolysis in Escherichia coli. Conversely, 
physiological levels of δ reversibly induce dormancy produce a sub-fraction of  
membrane-compromised cells, and a minor subpopulation of Bacillus subtilis cells become 
tolerant of toxin action. We report here that purified δ is a strong UNAG-dependent 
ATPase, being GTP a lower competitor. In vitro, δ toxin phosphorylates a fraction of 
UNAG. In vivo, δ-mediated inactivation of UNAG by phosphorylation does not deplete the 
active UNAG pool, because expression of the toxin enhances the efficacy of genuine cell 
wall inhibitors (fosfomycin, vancomycin or ampicillin). Transient δ expression together 
with fosfomycin treatment halt cell proliferation, but ε2 antitoxin expression facilitates the 
exit of δ-induced dormancy, suggesting that there is sufficient UNAG for growth. We 
propose that δ induces diverse cellular responses to cope with stress, being the reduction of 
the UNAG pool one among them. If the action of δ is not inhibited, e.g., by de novo  
ε2 antitoxin synthesis, the toxin markedly enhances the efficacy of antimicrobial treatment 
without massive autolysis in Firmicutes. 
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1. Introduction 
Microbial type II toxin-antitoxin (TA) systems, which are stress regulators, are generally composed 
of two genes organized in an operon, encoding a toxin (T) and an antitoxin (A) protein [1–3]. RelE and 
δ are the most abundant prokaryotic toxins in nature [4], with δ been the most ubiquitous toxin in 
Firmicutes [5,6]. The plasmid- or chromosomal-encoded TA complexes (δ-ε or PezT-PezA) consist of 
two monomeric long-living δ (PezT) toxins separated by a dimeric short-living ε2 (PezA2) antitoxin, 
forming a δε2δ (PezTPezA2PezT) inactive complex [7,8]. The toxins of the δ family are highly 
conserved, δ (286 amino acids long polypeptide) shares 42% of sequence identity with PezT  
(253 amino acids long). Both toxins have a very similar three-dimensional structure, and mutations in 
equivalent positions show similar phenotypes [7,8]. However, antitoxin ε (90 amino acids long 
polypeptide) only shares 17% of sequence identity with the C-terminal region of antitoxin PezA  
(158 amino acids long). Despite this low sequence identity, the C-terminal region of PezA folds into a 
three helix bundle similar to that of ε [7,8]. 
Both Firmicutes toxins, δ and PezT might interact with ATP-Mg2+ or GTP-Mg2+, with uridine 
diphosphate-N-acetylglucosamine (UNAG) and with ε2 (PezA) antitoxin [7,9]. These toxins, as part of 
the biological non-toxic heterotetrameric (δε2δ or PezTPezA2PezT) complex, interact with UNAG [9]. 
However, in this inactive complex, the toxin cannot interact with ATP-Mg
2+
/GTP-Mg
2+
, because the 
antitoxin helixes block the entry of the nucleotide cofactor into the binding pocket of the toxin through 
steric hindrance [7,8,10]. Toxin PezT phosphorylates the 3'-OH group, which is an essential precursor 
of bacterial cell wall biosynthesis, leading to phosphorylated, unreactive, UNAG-3P [9]. Toxin PezT 
was specific for UNAG, because it failed to phosphorylate uridine diphosphate-N-acetylgalactosamine [9]. 
Hence, δ /PezT toxin blocks the first committed step in the peptidoglycan synthesis pathway, that is the 
transfer of an enolpyruvate residue from phosphoenolpyruvate to position 3 of UNAG [9]. 
Toxin δ, under various stress stimuli, can be activated as a result of ε2 antitoxin degradation by 
stress-induced proteases or under conditions that prevent TA gene expression [8,11–13]. Such 
activation permits free wt δ (or its short-living variant (δY83C, half-life ~28 min)) to trigger a 
heterogeneous set of protective responses, and the expression of ~2% of total Escherichia coli or 
Bacillus subtilis genes, so that these toxins show a bacteriostatic, rather than a bactericidal  
behavior [12,14]. In B. subtilis cells, δY83C toxin expression increases RelA expression, reduces 
expression of lipid metabolism genes, and decreases the GTP pool without apparent alteration of the 
proteome within the first 15 min upon induction [12,14,15]. Within the 15–60 min interval, δY83C 
expression reduces the synthesis of macromolecules, decreases ATP levels, increases the alarmone 
guanosine (penta)tetraphosphate ([p] ppGpp) pool, and alters the membrane potential without affecting 
the SOS response [14,15]. Within 60–90 min, δY83C expression decreases the pool of a novel 
metabolite, probably UNAG [14]. Finally, expression of δ for 120–240 min leads to a fraction  
(25%–35%) of the population stained with propidium iodide (PI), suggesting a membrane 
compromise; but subsequent expression of the ε2 antitoxin facilitates the exit from the dormant state 
and a fraction of cells recover their membrane “alteration” [12,14,15]. A different effect is observed if 
B. subtilis cells express the wt δ or δY83C toxin for longer periods of time (>960 min). Here, the cells 
enter in a point of no return, and ε2 antitoxin expression cannot reverse the dormant state [12,16]. 
Conversely, in E. coli cells PezT over-expression inhibits cell wall synthesis and triggers autolysis  
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60 min after induction [9]. It is likely that toxin concentrations or time of exposure shows hormesis, 
complicating the understanding of δ toxin mode of action. 
1.1. Aims of the Experiments 
Previously, it was been proposed that a PezT variant lacking the C-terminus (PezTΔC242) 
instigates a suicide program with subsequent autolysis [9], but δ works as a checkpoint barrier 
inducing a reversible dormant state without massive cell lysis [14]. In the first outcome, PezT toxin 
may phosphorylate all the UNAG pool and by this way may provoke a cell membrane compromise and 
lysis, whereas δ toxin acts on different cellular processes, not only cell wall synthesis. In order to 
discriminate between these two hypotheses, different experimental approaches were used in this report. 
First, δ was purified, free of ε2 antitoxin, to test whether ATP hydrolysis is coupled or not with the 
phosphate transfer to UNAG. In addition, we analyzed whether GTP can be used as a donor of the 
phosphate group. Second, we tested whether δ expression depletes the UNAG pool or only reduces it. 
For that purpose, we used antimicrobials that inhibit cell proliferation by targeting cell wall synthesis 
with fosfomycin (Fos), vancomycin (Van), ampicillin (Amp) upon transient expression of the  
δY83C toxin variant in B. subtilis cells. Third, we studied if upon specific reversal of δ-induced 
dormancy B. subtilis cell proliferation is recovered or there is cell lysis. To perform the latter study δ 
was transiently expressed in the presence or absence of Fos, and then ε2 antitoxin was induced. Finally, 
we tested whether δ expression for long periods of time causes cell lysis in B. subtilis. 
2. Results and Discussion 
2.1. Toxin ζ Hydrolyses ATP in the Presence of UNAG 
Recently, it was documented that in the presence of ATP-Mg
2+
, δ toxin, in the presence of  
ε2 antitoxin, phosphorylates the cell wall precursor UNAG by attaching a phosphoryl group to the  
3'-hydroxyl group of the N-acetylglucosamine moiety to form UDP-N-acetylglucosamine-3'-phosphate 
(UNAG-3P) [9]. The low efficiency of this reaction, which was not stoichiometric, could be attributed 
to the presence of the antitoxin or because the phosphorylation reaction might be uncoupled from the 
ATPase reaction. In this work we have we tested whether δ toxin purified by a novel protocol, free of 
antitoxin (as described in the Experimental section), is able to hydrolyze ATP in the presence or 
absence of UNAG. We have also tested whether the hydrolysis reaction is coupled with the 
phosphotransfer reaction and if GTP could work as a donor of inorganic phosphate (Pi) for the transfer 
reaction. The products were separated from the substrate by thin-layer chromatography (TLC) and 
analyzed by autoradiography. 
In the presence of UNAG, δ toxin hydrolyzed [γ32P]-ATP, and we observed the accumulation of a 
radioactive product(s) which co-migrate with the front (data not shown). This was the expected 
position for the product of ATP hydrolysis, which is inorganic phosphate [
32
Pi]. We do not know how 
[γ32P]-UNAG-3P should migrate under the conditions used, but one hypothesis is that it co-migrates 
with the TLC front under the experimental conditions used. To address this, we perform experiments 
with other TLC eluents in order to separate [
32
Pi] from [
32
P]-UNAG-P, but we failed to have  
a significant separation of both of them under the conditions used (data not shown). Alternatively,  
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the reaction is uncoupled and [γ32P]-UNAG-P accounts only to a minor fraction of the  
radiolabelled product. 
To quantify the rate of ATP hydrolysis the experiments were performed using [α32P]-ATP. If δ 
hydrolyses [α32P]-ATP it should be converted onto [α32P]-ADP that runs faster than [α32P]-ATP in a 
TLC. The commercial radioactive [α32P]-ATP contains 6%–10% of [α32P]-ADP [17], hence this is our 
background level, and this was used in the TLC as an internal control that marked the respective 
running positions of substrates and products. In the absence of δ toxin no [α32P]-ATP hydrolysis was 
observed (Figure 1, lane 10). Purified δ toxin (0.5 µM) did not hydrolyze [α32P]-ATP (0.5 mM) in the 
absence of UNAG, but δ toxin hydrolyzed >85% of the ATP substrate upon addition of UNAG  
(2 mM), in a 60 min reaction (Figure 1, lanes 1 and 2). 
Figure 1. Uridine diphosphate-N-acetylglucosamine (UNAG)-dependent δ hydrolysis of 
ATP is poorly competed by GTP. Samples containing 2 mM UNAG and increasing 
concentrations of ATP (0.5, 5 and 10 mM (with a fixed concentration of α32P-ATP,  
10 nM), lanes 2–4) or 2 mM UNAG and a fixed concentration of ATP (0.5 mM [α32P-ATP, 
10 nM]) and increasing GTP concentrations (1.25, 2.5, 5, 7.5 and 10 mM, lanes 5–9) were 
incubated with 0.5 µM δ toxin for 30 min at 30 °C in buffer B. ATP hydrolysis was 
analyzed by thin-layer chromatography (TLC) performed on polyethyleneimine-cellulose 
plates with 0.85 M KH2PO4 (pH 3.4) as the mobile phase, followed by autoradiography. 
 
When saturating ATP concentrations were used, also a large fraction of the ATP was hydrolyzed 
(Figure 1, lanes 3 and 4). At ATP:UNAG ratios of 2.5:1 or 5:1 ~70% and ~40% of radiolabelled 
[α32P]-ATP was converted onto [α32P]-ADP, respectively, in a 60 min reaction (Figure 1, lanes 3  
and 4). Since the conversion of ATP onto ADP was significantly higher than if each Pi generated was 
transferred to the 3'-OH group of the sugar moiety of UNAG, we tentatively assume that the reaction is 
not tightly coupled. Previously, it was shown that δ toxin, in the presence of ATP-Mg2+ and the  
ε2 antitoxin, attaches a phosphoryl group to the 3'-hydroxyl group of the N-acetylglucosamine moiety 
to form UDP-N-acetylglucosamine-3'-phosphate (UNAG-3P) [9]. Hence we assume that δ toxin alone 
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(free of ε2 antitoxin) would also transfer the Pi to form UNAG-3P, but it remains to be shown whether 
the 3'-OH group of the sugar moiety of UNAG is the only target of the phosphorylation reaction. 
To verify the structurally suggested preference for ATP vs. GTP (as reported for other 
phosphotransferases) as substrate, we performed competition experiments. Here, δ toxin was incubated 
with increasing ATP or GTP concentrations containing a fixed amount of ATP (0.5 mM ATP 
containing [α-32P]-ATP 10 nM) and UNAG (2 mM). Toxin δ can hydrolyze ATP with similar 
efficiency in the presence of a 2.5-fold excess of GTP (Figure 1, lane 5). GTP:ATP ratios of 5:1 to 
10:1, marginally decreased δ-mediated [α32P]-ATP hydrolysis (Figure 1, lanes 6 and 7). At GTP:ATP 
ratios of 15:1 and 20.5:1, ~37 and ~46% of [α 32P]-ATP was not converted to [α32P]-ADP, respectively 
(Figure 1, lanes 8 and 9). It is likely therefore that: (I) δ toxin is preferentially a UNAG-dependent 
ATPase; (II) the phosphotransfer reaction might not simply be a one-step coupled reaction; and (III)  
δ toxin preferentially hydrolyzed ATP-Mg2+ over GTP-Mg2+ in the presence of UNAG. 
2.2. Toxin ζ Phosphorylates a Fraction of UNAG In Vitro 
In the previous section was shown that δ requires the presence of UNAG to hydrolyze ATP, 
suggesting that UNAG or UNAG-3P might stimulate δ-mediated ATP hydrolysis. To further analyze 
this, UNAG and ATP were incubated in the absence or presence δ and the products of the reaction 
were analyzed by mass spectrometry as described in the Experimental section. 
In a mock reaction, lacking the δ toxin, phosphorylated UNAG was not observed (compare  
Figure 2A,B). In all conditions the nucleotide (or compound) and its Na-bound (e.g., M-H
+
  
[ATP, 506.06 peak], the M-2H
+
-Na
+
 [ATP-Na2, 528.05 peak] or even M-3H
+
-2Na
+
 forms (due to the 
contribution of the buffer used) were detected (Figure 2A). In the presence of δ toxin, a massive 
degradation of the ATP pool (506.06 Da peak, expected 507.18 Da) with subsequent accumulation of 
ADP (426.06 Da peak, expected 427.20 Da) was observed. However, the proportion of UNAG  
(606.15 Da UNAG peak, expected 607.35 Da) converted into a 687.35 Da product (UNAG-3P) with a 
small peak at 686.12 Da (UNAG-3P-Na2) was detectable but poor (Figure 2). A parallel TLC analysis 
of this reaction revealed that δ toxin hydrolyzed more than 95% of the ATP substrate (data not shown). 
As revealed in Figure 2B, in the presence of δ toxin traces of the ATP pool and a reduced fraction 
of UNAG were detected by mass spectrometry, when compared to the absence of δ toxin (Figure 2A). 
Since traces of ATP and a significant fraction of UNAG remained after 30 min reaction, it was 
assumed, as done in the previous section (Figure 1), that only a fraction of the Pi was transferred to 
UNAG to generate UNAG-3P (Figure 2B). Alternatively, δ toxin phosphorylates UNAG in a coupled 
reaction, but under the conditions used we are loosing a fraction of the accumulated inactive  
UNAG-3P product. 
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Figure 2. δ toxin phosphorylates in vitro a fraction of UNAG. Samples containing 2 mM 
UNAG and 0.5 mM ATP were incubated in the absence (A) or presence (B) of δ toxin  
(0.5 µM) for 60 min at 30 °C in buffer B. The reaction products were analyzed by mass 
spectroscopy. The peaks corresponding to relevant products (ATP, ADP, UNAG and 
UNAG-3P) are indicated. The intensity (×10
4
) was expressed in arbitrary units (a.u.).  
In panel B, the 675 to 740 m/z section is enlarged in the insert. 
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2.3. Toxin ζY83C Leaves Significant Amounts of UNAG In Vivo 
In vitro assays showed that δ is a poor kinase, phosphorylating only a fraction of the UNAG 
present. However, these assays might not extrapolate to the in vivo situation. It could be that in vivo 
there is(are) some unknown factor(s) that may stimulate the phosphotransfer reaction. To test whether 
δ toxin reduces or depletes the UNAG pool in vivo, and by this way it reduces or blocks the 
biosynthetic pathway of peptidoglycans different types of antimicrobials, which act at different levels 
of the two stage process of cell wall biosynthesis, were used. 
It has been established that the first step of peptidoglycan (murein) biosynthesis is a cytosolic stage 
that consists in the transfer of an enolpyruvate moiety from phosphoenolpyruvate (PEP) to the  
C3 position of N-acetylglucosamine moiety of UNAG, a reaction catalyzed by two MurA enzymes in 
Firmicutes (the ubiquitous MurA [MurAA or MurA1] and MurAB [or MurA2] [18]), to yield 
enolpyruvyl-UDP-N-acetylglucosamine (EP-UNAG). The synthesis of these murein precursors can be 
inhibited by: (I) δ-mediated phosphorylation of UNAG to form unreactive UNAG-3P; and (II)  
a naturally occurring PEP analogue, Fosfomycin (Fos), which binds covalently to the active site of 
MurAA (or MurAB). Fos, in the presence of the UNAG substrate inhibits cell wall biosynthesis by 
blocking the accumulation of EP-UNAG [19,20]. EP-UNAG is transformed by a series of cytosolic 
steps, which results in the formation of the UDP-N-acetyl-muramic acid-pentapeptide that is translocated 
to the membrane acceptor and through different steps the N-acetylglucosamine/N-acetylmuramic  
acid-pentapeptide is covalently linked to the lipid carrier molecule undecaprenol via a pyrophosphate 
ester bridge (Lipid II). Vancomycin (Van) prevents incorporation of N-acetylglucosamine and  
N-acetylmuramic acid-peptapeptide subunits into the peptidoglycan matrix, and interferes with the 
Lipid II cycle [21]. Then, the Lipid II building block is used as the substrate for the polymerization 
reaction, consisting of the assembly into glycan chains by transglycosilation and peptide cross-linking 
of the pentapeptide moiety by transpeptidation, reactions catalyzed by Classes A or B penicillin-binding 
proteins [22–24]. Amp acts as an irreversible inhibitor of these transpeptidases [25,26]. 
We reasoned that if δ toxin depletes the UNAG pool, cells will become tolerant to antimicrobials 
that act downstream of toxin action, leading to non-inheritable drug tolerance (persistence). To test this 
hypothesis, δ toxin induced cells were exposed to Fos, Van or Amp and the antimicrobial drug 
tolerance was analyzed. These antimicrobials, in addition of inhibiting cell wall synthesis as explained 
above, induce two regulatory systems to cope with stress in Firmicutes: the extracytoplasmic function 
(ECF) σ factors and/or cell envelope stress-sensing two component systems, which are linked to other 
stress responses [27]. Van, which is the strongest cell envelope-perturbing agent, induces the synthesis 
of a large number of genes controlled by specific σ factors (σV, σM, σW and σY) and two components 
systems (e.g., LiaRS), Fos alters the expression of genes controlled by σM and σW; and Amp alters the 
expression of genes through cell envelope stress-sensing two component systems (e.g., BlaRI,  
MecRI) [27]. If the three antimicrobials show a similar behavior upon δ toxin we can omit any specific 
contribution of cell envelop stress. 
To perform these experiments we took advantage of the short-lived toxin variant, δY83C  
(half-life ~28 min) under control of a Xyl inducible promoter (xylR PXylAδY83C expression cassette) 
(Table 1). The level of toxin in non-induced BG689 cells is too low (<10 δY83C monomers/colony 
forming units, CFUs) to measurably alter the growth rate in minimal medium S7 (MMS7) [12]. 
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Previously it was observed that induction of the xylR PXylAδY83C cassette (BG689 cells), by addition 
of 0.5% Xyl, increased δY83C levels to a plateau with a toxin concentration of ~300 toxin 
monomers/CFUs at ~10 min, and the steady-state level of the toxin remained for at least 240 min [12]. 
When exponentially growing BG689 cells, growing in MMS7, reached moderate-density (~5 × 10
7
 
cells/mL) xylose (Xyl) 0.5% was added to express δY83C toxin as described Materials and  
Methods [14,15]. As already observed, transient exposure to sub-physiological concentrations of free 
δY83C induced dormancy and produced a typical biphasic survival curve, with a sub-fraction of cells 
(1–5 × 10−5 cells) non-inheritable tolerant to toxin action upon 120 min of exposure (Figure 3) [14,15]. 
Table 1. Bacterial strains used. 
Strains Relevant genotype Reference 
BG687 a +xylR, PxylA, cat [12] 
BG689 a +xylR, PxylA δY83C, cat [12] 
BG1127 a +lacI, Phsp, spc, [pCB799, xylR, PxylA ε, cat] [12] 
BG1125 a,b +lacI, Phsp δ, spc, [pCB799, xylR, PxylA ε, cat] [12] 
BL21(DE3) c +[pCB920, PT7 δ gene, Pω ω and ε genes, bla] This work 
a The B. subtilis strains are isogenic with BG214 (trpCE metA5 amyE1 ytsJ1 rsbV37 xre1 xkdA1 attSPβ attICEBs1); 
b BG1125 cells bearing pCB799-borne ε gene were grown in MMS7 containing 0.005% Xyl to titrate basal 
expression of the wt δ toxin; c E. coli BL21(DE3) genotype (ompT gal (λ DE3, int::lacI-PlacUV5 T7 gene 1) 
fhuA2 (dcm) ΔhsdS). 
When exponentially growing BG689 cells (~5 × 10
7
 cells/mL in MMS7) were transiently exposed 
to Fos or Amp (at twice the minimal inhibitory concentration [MIC]) or to Van (at 4 times the MIC) 
for 120 min, these bactericidal antimicrobials caused a cessation of cell proliferation, and rendered a 
fraction of 0.8 to 5 × 10
−3
 phenotypic tolerants (Figure 3). This multidrug tolerance of the isogenic 
population of antimicrobial sensitive cells is termed bacterial persistence [28–30]. 
To test whether toxin action depletes the UNAG pool and this leads to enhanced antimicrobial 
persistence when cells are treated with cell wall inhibitors moderate-density exponentially growing 
BG689 cells were treated with Xyl (to induce δY83C toxin expression) and transiently exposed to the 
antimicrobial. Experiments are showed when the two compounds (i.e., Xyl and the antimicrobial) were 
added simultaneously, but the same results were obtained when first cells were exposed to toxin action 
for 30 min, and later the antimicrobial was added. Toxin δY83C expression and Fos, Van or Amp 
treatment additively decreased the rate of cell survivals to 0.9 to 2 × 10
−6
 (Figure 3). Since the three 
antimicrobial show a similar outcome in the presence of free δY83C toxin, it is unlike that the 
enhanced sensitivity could be attributed to a perturbation of cell envelop stress (see above). It is likely 
that: (I) δ toxin expression only decreases the UNAG pool, and Fos, Van or Amp use the remaining 
fraction to further inhibit the plating of toxin tolerant cells; and (II) δ toxin expression additively 
enhances the efficacy of the antimicrobials rather than making cells insensitive to Fos, Van or Amp 
treatment. Alternatively, transient expression of δ toxin, by inactivating the UNAG substrate, inhibits 
the action of the MurA-MurF enzymes, and this inhibition leads to loss of cell shape and integrity, 
with cells becoming more prone to autolysis, when they are additionally treated with any of  
these antimicrobial. 
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Figure 3. Cell wall inhibitors and δ toxin expression show an additive effect. BG689 cells 
containing the short living δ variant (δY83C) gene were grown to ~5 × 107 cell/mL in 
MMS7. Then Xyl (0.5% to induce expression of the δY83C toxin) or an antimicrobial or 
both was added and the culture was incubated for 120 min. Cells were washed and 
appropriate dilutions were plated to count the survivals. The results are the average of at 
least four independent experiments and are within a 10% standard error. 
 
2.4. Prolonged Action of Toxin ζY83C Does not Induce Massive Cell Lysis 
To test the latter hypothesis were analyzed if prolonged expression of sub-physiological 
concentrations of δY83C (360 or 480 min) might exhaust the metabolite pool and BG689 cells might 
reach the limits of their “capacity” to exit the dormant state, and they cannot be longer rescued from 
the “point of no return”. As already observed, after 16 h of δY83C toxin expression the survival rate 
drops to 2–8 × 10−7 [16]. 
BG689 cells were grown up to optical density (OD600) of 0.2 in MMS7 and divided into two 
aliquots. To one aliquot inducer (0.5% Xyl) was added (time zero) and samples were collected at 
different times (120, 240, 360 and 480 min after induction) (Figure 4). In the presence of Xyl, the 
increment in OD600 halted after one doubling time, and remained constant during the 480 min  
interval (Figure 4A). At these time points, samples were withdrawn, and the cells were stained with 
membrane-permeant SYTO 9 (green fluorescence) and membrane-impermeant PI (red fluorescence), 
appropriate dilutions were plated in LB plates and the survival rate was measured (Figure 4B). 
Transient expression of δY83C toxin for 120 min or longer periods of time induced dormancy, and a 
similar sub-fraction of 2–6 × 10−5 survivals became tolerant of toxin action (Figure 4B). Within the 
first 360 min of δY83C toxin expression, the proportion of PI permeable cells slightly increased  
(~1.2-fold). At later times (480 min) the proportion of PI stained cells increased ~2-fold (~65% of total 
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cells stained with PI) with respect to the proportion of cells stained with PI after 120 min of toxin 
expression (Figure 4B). It is likely that prolonged δY83C expression might not induce massive cell lysis. 
Figure 4. Effect of prolonged action of toxin δY83C on membrane permeability and cell 
survival. (A) Growth curve of BG689 cells containing δY83C gene. Cells were grown to 
~2.5 × 10
7
 cell/mL in MMS7 (OD600 = 0.2), to half of the culture Xyl (0.5%) was added to 
induce δY83C expression (time zero) and OD600 was followed over time in the two 
cultures. The arrow denotes the time of Xyl (0.5%) addition; (B) Aliquots of the cultures 
were taken at time zero, 120, 360 and 480 min after Xyl addition (denoted as +). The cells 
were fixed, stained with SYTO 9 and PI, and analyzed by fluorescence microscopy (black 
lane), at the same time, cells were washed and appropriate dilutions were plated in LB 
plates to count the survivals. The numbers of relative CFUs (black bars) at the indicated 
times after δY83C toxin expression are relative to the non-induced control at the same time 
(denoted as -) taken as 1 (grey bar). Error bars show 95% confidence intervals of more than 
three independent experiments. 
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When similar experiments were performed in E. coli cells a different outcome is observed 
depending of the growth medium rather than the speed of growth [9,31]: In LB medium (doubling time 
~28 min), 60 min after overexpression of PezTΔC242, cells underwent a massive death with few surviving 
cells showing an ovoid morphology [9]; in supplemented M9 medium (doubling time ~33 min),  
δ toxin over-expression induced dormancy, and 60 min after induction massive filamentation,  
with subsequent growth recovery at later times was observed [31]. At present, the source of these 
discrepancies remains unknown. 
2.5. Toxin ζ Reversibly Induces a Halt in Cell Proliferation 
Previously, it was shown that transient exposure (120 min) to physiological concentrations of  
free wt δ reversibly induces dormancy, produces a sub-fraction of membrane-compromised cells to be 
stained with PI (25%–35% of total cells), and a minor subpopulation of B. subtilis cells  
become tolerant of toxin action. Subsequent expression of the ε2 antitoxin facilitates the exit from the 
dormant state and a fraction of membrane compromised cells recover their alteration of the  
membrane potential [14]. 
Toxin δ expression inactivated a fraction of UNAG and Fos used the remaining fraction of 
unphosphorylated UNAG to further inhibit cell proliferation (see Figure 3). If δ toxin expression only 
reduces the UNAG pool and/or UNAG-P poisons the exit from the dormant state, expression of ε2 
antitoxin might lead to different outcomes in the presence of Fos: First, if δ toxin expression and Fos 
addition deplete the UNAG pool, cells should not be recovered by antitoxin expression and cell wall 
biosynthesis can be rescued only after de novo synthesis of UNAG or UNAG-3P has to be re-activated 
by an unknown pathway. Second, the concert action of both δ toxin expression and Fos addition 
triggers cell lysis by unbalancing the control of peptidoglycan biosynthesis. Finally, if δ toxin 
expression decreases a fraction of the UNAG pool, without depleting it, ε2 antitoxin expression may 
reverse toxin action and the remaining UNAG is used to rescue cell proliferation. To discriminate 
between all these possible outcomes, cell survival and the proportion of PI stained cells were analyzed 
after ε2 antitoxin expression. 
When exponentially growing BG1125 cells (Table 1) reached a moderate-density (~5 × 10
7
 cells/mL 
in MMS7) 1 mM IPTG was added to induce δ toxin expression. As already observed, expression of 
nearly physiological wt δ toxin concentrations for 120 min induced dormancy, a fraction of the cell 
population (~30%) was stained with PI, and ~1 × 10
−5
 survivals tolerant to toxin action were obtained 
(Table 2). Subsequent expression of the ε2 antitoxin, after 120 min of IPTG addition, by Xyl (0.5%) 
addition, led to exit of the dormant state with CFUs increasing ~5000-fold, and only a small fraction  
(~10%) of cells were stained with PI (Table 2) [14,15]. Alternatively, resumption of cell growth might 
dilute the relative proportion of PI stained cells up to 10% of total cells. 
In the absence of IPTG, addition of Fos to moderate-density exponentially growing BG1125 cells 
for 120 min reduced plating efficiency of the cells to levels similar to the ones observed in the BG689 
background (~3 × 10
−3
 survivals), and as expected for a bactericidal antimicrobial the proportion of 
cells permeable to PI increased (~70% of total cells) (Table 2). Expression of the ε2 antitoxin under 
these conditions did nor alter the observed outcome (~70% of total cells stained with PI, and ~3 × 10
−3
 
survivals). When moderate-density exponentially growing BG1125 cells were exposed to toxin  
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(by addition of 1 mM IPTG) and Fos action, the toxin markedly enhanced the efficacy of Fos treatment, 
but no additive effect on membrane permeation to PI was observed (Table 2). Then, transient 
expression of the ε2 antitoxin led to partial exit of the dormant state, which increased >2000-fold 
CFUs, but it failed to decrease the proportion of PI permeable cells (Table 2). It is likely that: (I) toxin 
expression enhances Fos sensitivity, and such effect does not seem to correlate with increased rate of 
cell lysis; (II) neither toxin expression nor Fos addition deplete the UNAG pool, because ε2 antitoxin 
expression facilitates the exit of the dormant state of a large fraction of cells; and (III) unregulated 
levels of murein synthesis, by transient toxin expression and Fos addition, do not induce massive cell 
autolysis. We propose that δ toxin and Fos decrease the UNAG pool, but when ε2 antitoxin expression 
halts δ toxin activity, by forming an inactive complex (δε2δ), the remaining active fraction of UNAG is 
processed by MurA enzymes and cells exit the δ-induced dormant state with resumption of growth as 
expected for a toxin that is bacteriostatic in nature. 
Table 2. Additive effect of δ toxin on Fos action and ε2 reversion of δ-induced dormancy. 
Conditions 
a
 TA 
c
 % PI stained cells 
d CFUs e 
- δ− ε(+) 2.6 (1250) 2.3 × 108 
+IPTG b δ+ ε(+) 30 (1314) 3.8 × 103 
+IPTG + Xyl b δ+ ε+ 9.8 (1642) 2.2 × 107 
+Fos δ− ε(+) 73 (1055) 6.7 × 105 
+Fos + Xyl b δ− ε+ 70 (1432) 6.6 × 105 
+IPTG b + Fos  δ+ ε(+) 75 (1247) <1.0 × 102 
+IPTG + Fos + Xyl b δ+ ε+ 68 (1560) 2.3 × 105 
a BG1125 (δ+) cells bearing pCB799-borne ε gene were exponentially grown to ~5 × 107 cells/mL in MMS7 
containing 0.005% Xyl (denoted as ε(+)); b Then, IPTG (1 mM to express δ toxin) or Fos (2 × MIC) or both 
agents simultaneously were added and the cells incubated for 120 min. In the conditions where Xyl (0.5%) 
was added at min 120 (to express wt ε2 antitoxin, denoted as ε
+), the cells were further incubated for 30 min 
and CFUs were counted on LB plates containing also Xyl; c The presence or the absence of induction of δ or 
ε gene is indicated with a + or –, respectively, and the (+) symbol denotes the low level of expression of the ε 
gene by addition of 0.005% Xyl necessary to titrate basal expression of the wt δ toxin; d The percentage of 
cells stained with PI are indicated and number of cells analyzed are shown in parentheses; e CFUs/mL were 
measured by plating appropriate dilutions on LB or LB-Xyl (0.5% final concentration) plates. The results are 
the average of at least four independent experiments and are within a 10% standard error. 
3. Experimental Section 
3.1. Bacterial Strains, Media and Growth Conditions 
The bacterial strains BG689 and BG1125 bearing pCB799 used in this study were previously 
reported [12] and are described in Table 1. Addition of low Xyl concentration (0.005%) to BG1125 
bearing pCB799 allowed the synthesis of low but significant ε2 antitoxin levels, expressed from 
pCB799-borne ε gene, necessary to titrate the basal δ toxin levels and to avoid genetic  
rearrangements [14]. BG1125 cells bearing pCB799-borne ε gene were grown in the presence of low 
levels of Xyl (0.005%) necessary to induce a basal expression of the ε2 antitoxin. Low levels of the  
ε2 antitoxin are necessary to titrate the ~40 δ toxin monomers/CFUs that are produced from escapes of 
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LacI repression in the BG1125 strain. Addition of 1 mM IPTG, increased δ toxin to a plateau 
concentration of ~1,700 wt δ monomers/CFU at ~30 min, and the steady-state level of δ remained for 
at least 240 min [see 14,15]. This toxin concentration is comparable to the level of wt δ toxin, when the 
gene is in its native context and transcribed from its native promoter (cells bearing pBT233-borne ωεδ 
operon that are neutralized by saturating ε2 antitoxin concentrations) [11]. 
Expression of the xylR PxylA δY83C cat cassette (BG689 strain) was induced by addition of  
0.5% Xyl and expression of the lacI Phspδ spc cassette (BG1125 strain) by addition of 1 mM IPTG. 
The BG689 or BG1125 bearing pCB799 isogenic strains were grown to mid-exponential phase  
(~5 × 10
7
 cells/mL) at 37 °C in MMS7 supplemented with the required amino acid (methionine and 
tryptophan) at 50 µg/mL [12]. 
The antimicrobial, except Van, used a 4-times MIC, was added at twice MIC. Cells were taken after 
120 min, washed with fresh pre-warmed media (to remove the inducer and/or antimicrobial) and 
appropriated dilutions were plated on LB agar plates containing glucose (which switches off δY83C 
expression) or on LB agar plates containing or not Xyl to express the ε2 antitoxin (δ toxin cassette). 
The survival rate, derived from the number of CFUs obtained in a given condition relative to the CFUs 
of the non-induced/non-antimicrobial treated control is documented. 
The MIC of the different antimicrobials tested was estimated by exposing 1–3 × 106 cells/mL for 16 h 
at 37 °C in MMS7 with shaking (240 rpm) to different concentrations of the antimicrobials employed, 
and is the mean of the minimum concentration that gave no growth in three independent experiments. 
In the absence of inducer, the presence of the δY83C (BG689 strain) or δ gene and pCB799-borne  
ε gene (BG1125) does not affect the MIC [15]. 
For δ toxin purification the stop codon of the δ gene was replaced by 6 His and a stop codon. This  
δ variant shows the same phenotype that wt δ when expressed in B. subtilis cells [16]. This δ gene 
variant was non-clonable in E. coli cells under the transcriptional control of the T7 RNA  
polymerase-dependent promoter (PT7), but cloning of the ω and ε genes, under its native RNA 
polymerase σA-dependent promoter (Pω), in opposite orientation, overcame the toxicity exerted by the 
δ variant, leading to pCB920 (Table 1). 
3.2. Fluorescence Microscopy 
To determine the proportion of “membrane-compromised” cells, they were harvested by 
centrifugation, washed to remove toxin inducer and/or the antimicrobial, and were stained with SYTO 9, 
which stains all bacteria with green fluorescence, and PI, which stains membrane-compromised 
bacteria with red fluorescence, according to the manufacturer’s instructions (Molecular Probes, 
Leiden). Cells were visualized using a BX61 Olympus microscope and Olympus CCD DP70 camera, 
with the appropriate filters as described [12]. 
3.3. Protein Purification 
Plasmid pCB920-borne δ, under the control of promoter 10 of phage T7 (P10), and ε gene under the 
control of native Pω, was used to overexpress δ in E. coli BL21(DE3) cells harboring pCB920. IPTG 
was added to induce the expression of T7 RNAP (lacI lacUV5 T7 gene 1), and 30 min later rifampicin 
was added to selectively block the expression of the ω and ε genes. After 120 min of  
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δ expression from rifampicin-resistant P10, and full decay of the ε2 antitoxin, the cells were harvested. 
The over-expressed long-living δ toxin was purified in two steps as follows: cells were lysed using the 
French Press in buffer A (50 mM phosphate buffer pH 7.5, 100 mM NaCl, 5% glycerol), and soluble  
δ protein was bound to a Ni-NTA column, and eluted using an imidazole gradient (2 to 75 mM). The 
fractions containing the δ protein were diluted to 25 mM NaCl, and loaded in a Q Sepharose column. 
Protein δ was eluted in buffer B (50 mM Tris-HCl pH 7.5, 5% glycerol) containing a gradient of NaCl 
(25 to 150 mM). The fractions containing the δ protein were dialyzed against buffer C (50 mM  
Tris-HCl pH 7.5, 100 mM NaCl) containing 50% glycerol and stored at −20 °C. 
3.4. Biochemical Assays 
The ATPase or GTPase activity of δ was measured by incubating increasing ATP or GTP 
concentrations (containing 10 nM [α-32P]-ATP) and a fixed amount of UNAG (2 mM) with purified 
toxin in buffer A (50 mM Tris-HCl pH 7.5; 50 mM NaCl; 1 mM MgCl2) at 30 °C. Then, TLCs of the 
radiolabeled nucleotides or sugar nucleotides were performed on polyethyleneimine-cellulose plates 
with 0.85 M KH2PO4 (pH 3.4) as the mobile phase as described [14] followed by autoradiography. 
Quantitative production of UNAG-3P, degradation of ATP and accumulation of ADP was 
determined by Maldi-TOF analysis as described [32]. ATP and UNAG were incubated or not with  
δ toxin in buffer B (10 mM Tris-HCl, pH 7.5, 50 mM NaCl, 1 mM MgCl2) for 30 min. Equal volume 
of the analyte solution (1 µL) was mixed with 1 mL of matrix solution (2,4,6 trihydroxyacetophenone 
or 2,3,6-trihydroxyacetophenone, 10 mg/mL in acetonitrile/water, 1:1 v/v) and 1 mL of ammonium 
citrate (50 mg/mL in water). Then 1 mL of the mixture was applied to the MALDI-TOF sample plate 
and air dried. The mass spectra were acquired using a Ultraflex III TOFTOF (BRUKER) mass 
spectrometer (equipped with a ND:YAG laser) operating in negative reflector mode. 
4. Conclusions 
Toxin δ-mediated dormancy induction can be attributed to the reduction of the ATP and/or GTP 
pools, the increment of the (p) ppGpp pool size and the accumulation of unreactive UNAG-3P among 
other changes (this work) [9]. We report here that purified δ is mainly an UNAG-dependent ATPase 
rather than a GTPase. Preliminary data suggested that ATP hydrolysis and accumulation of unreactive 
UNAG-3P are not strictly coupled reactions. Our results indicate that physiological δ toxin 
concentrations enhance the efficacy of antimicrobials that inhibit cell wall biosynthesis (Figure 3).  
A similar δ-mediated sensitization to other three different classes of antimicrobials was reported 
previously [15]. 
Our results are incompatible with the hypothesis that δ or PezT depletes the UNAG pool to generate 
an irreversible positive feedback loop, and as the cell wall blockage takes effect, cell wall weakening 
should instigate a suicide program and autolysis [9]. We surmise that cells can readjust their 
metabolism during situations where δ toxin activation is temporary and reversible. Our in vivo 
experiments suggest that transient δ toxin expression (120 min) reversibly induces a dormant state, 
leads to a sub-fraction (25%–35%) of the population stained with PI, and a minor subpopulation of 
cells exhibits non-inheritable toxin tolerance. Similarly, addition of Fos triggers stasis, leads to a 
fraction (65%–75%) of PI stained cells (suggesting cell death), and a minor subpopulation of cells are 
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stochastically tolerant to Fos action. After δ toxin expression and Fos addition, subsequent expression 
of the ε2 antitoxin specifically reverses δ-induced dormancy, but it fails to reduce the proportion of 
Fos-induced PI stained cells. 
From the results obtained in this work and previous results, we propose that the modus operandi of 
δ toxin is to induce diverse responses to cope with stress, and reduction of the UNAG pool is one 
among them, rather than instigating a suicide program by depleting UNAG. A similar scenario is 
observed upon long time δ toxin accumulation (360 or 480 min). Here, tolerant cells might enter into 
the viable-but-nonculturable state, but massive cell lysis was not observed. Conversely, after 60 min 
over-expression in E. coli cells, the PezTΔC242 toxin blocks cell wall synthesis and triggers massive 
autolysis with few intact cells with an ovoid morphology [9], but such massive autolysis was not 
observed upon δ toxin over-expression [31]. It is likely that the truncated and attenuated version of the 
PezT toxin (PezTΔC242) is bactericidal rather than bacteriostatic in nature. 
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